NurExone Biologic Inc — Proxy Solicitation & Information Statement 2023

Apr 21, 2023

April 21, 2023

==> picture [97 x 18] intentionally omitted <==

324-8th Avenue SW, 8th floor Calgary AB, T2P 2Z2 www.computershare.com

To: All Canadian Securities Regulatory Authorities

Subject: NUREXONE BIOLOGIC INC.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type : Annual and Special Meeting Record Date for Notice of Meeting : May 18, 2023 Record Date for Voting (if applicable) : May 18, 2023 Beneficial Ownership Determination Date : May 18, 2023 Meeting Date : June 28, 2023 Meeting Location (if available) : Toronto, ON Issuer sending proxy related materials directly to NOBO: No Issuer paying for delivery to OBO: Yes

Notice and Access (NAA) Requirements:

NAA for Beneficial Holders No NAA for Registered Holders No

Voting Security Details:

Description CUSIP Number ISIN COMMON CLASS 67059R109 CA67059R1091

Sincerely,

Computershare

Agent for NUREXONE BIOLOGIC INC.